Home Cerenis Therapeutics

Cerenis Therapeutics

In operation
IPO
Developer of New HDL Therapy

Basic Information

Cerenis Therapeutics is a multinational biotechnology company dedicated to the discovery, development, and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases.
Cerenis Therapeutics Holding SA
Central-LoireValley,France
15~50 people
January 01, 2005
info@cerenis.com